Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
28 Results for "
osteocalcin
" in MedChemExpress (MCE) Product Catalog:
Products (28)
28 Results for "osteocalcin" in MCE Product Catalog:
4
4 Cited Publications
Cat. No.: HY-P81217
Synonyms: osteocalcin Propeptide; Gamma-carboxyglutamic acid-containing protein; Bone Gla-protein; BGLAP; Bone gamma carboxyglutamate protein; BGLAP; BGP; Bone gamma carboxyglutamate gla protein osteocalcin; Bone gamma carboxyglutamate protein; Bone Gla protein; Gamma carboxyglutamic acid containing protein; OC; PMF1; OSTCN_HUMAN.
2
2 Cited Publications
Category:
Vaccaria segetalis (Neck.) Garcke Cyclopeptides Metabolic Disease Plants Disease Research Fields Caryophyllaceae
Target:
Cat. No.: HY-B2172
CAS No.: 12001-79-5
Category:
Cardiovascular Disease Natural Products other families Microorganisms Animals Plants Disease Research Fields
Target:
Cat. No.: HY-P4588
CAS No.: 1927927-11-4
Target:
Research Areas:
Cat. No.: HY-N4119
CAS No.: 13241-32-2
Category:
other families Flavonoids Flavonones Phenols Polyphenols Plants
Target:
Research Areas:
ER 50891 is a RARα antagonist. ER 50891 can significantly antagonize the inhibitory effect of all-trans retinoic acid (ATRA) on the total cell metabolic activity and proliferation of MC3T3-E1 preosteoblasts. ER 50891 rescues ATRA-inhibited osteocalcin (OCN) expression and extracellular matrix mineralization, and suppresses alkaline phosphatase (ALP) activity synergistically. ER 50891 can be used for the study of osteoporosis related to ATRA-induced inhibition of osteoblastogenesis .
Cat. No.: HY-P2588
CAS No.: 136461-80-8
Synonyms: osteocalcin (1-49) (human)
Target:
Research Areas:
Cat. No.: HY-P10413
Target:
Research Areas:
Cat. No.: HY-13636A
CAS No.: 1316849-17-8
Synonyms: ICI 182780 (S enantiomer); ZD 9238 (S enantiomer); ZM 182780 (S enantiomer)
Research Areas:
Fulvestrant (ICI 182780; ZD 9238) S enantiomer is the S-enantiomer of Fulvestrant (HY-13636), a potent estrogen receptor inhibitor. Fulvestrant binds to and blocks the estrogen receptor, promotes its degradation, and thereby inhibits receptor dimerization, nucleocytoplasmic shuttling and transcriptional activity. Fulvestrant effectively blocks estrogen signaling, MAPK pathway activation and ER-regulated protein expression. Fulvestrant induces apoptosis, inhibits the proliferation of breast cancer and prolactinoma cells, and reduces the mineralization level, alkaline phosphatase activity and osteocalcin expression of preosteoblasts. Prenatal exposure to Fulvestrant impairs ovarian follicular development and causes ovarian structural damage. Fulvestrant has been widely used in studies related to breast cancer, prolactinoma and other conditions .
Cat. No.: HY-P3738
CAS No.: 120944-72-1
Target:
Research Areas:
Cat. No.: HY-P4587
CAS No.: 1802086-27-6
Target:
Research Areas:
Cat. No.: HY-P3735
CAS No.: 85679-70-5
Cat. No.: HY-P10462
CAS No.: 1403753-45-6
Synonyms: Synthetic anti-inflammatory peptide 15
Research Areas:
Cat. No.: HY-P4835
CAS No.: 247902-18-7
Target:
Research Areas:
Cat. No.: HY-P2588A
Synonyms: osteocalcin (1-49) (human) TFA
Target:
Research Areas:
Cat. No.: HY-P10126
Target:
Research Areas:
Cat. No.: HY-108531A
Purity: 99.86%
ER 50891 quarterhydrate is a RARα antagonist. ER 50891 can significantly antagonize the inhibitory effect of all-trans retinoic acid (ATRA) on the total cell metabolic activity and proliferation of MC3T3-E1 preosteoblasts. ER 50891 rescues ATRA-inhibited osteocalcin (OCN) expression and extracellular matrix mineralization, and suppresses alkaline phosphatase (ALP) activity synergistically. ER 50891 can be used for the study of osteoporosis related to ATRA-induced inhibition of osteoblastogenesis .
Cat. No.: HY-P3740
Target:
Research Areas:
Cat. No.: HY-114154
CAS No.: 239066-73-0
Target:
Research Areas:
AL-438 is a potent, selective and orally active glucocorticoid receptor modulator with Kis of 2.5, 1786, 53, 1440, >1000 nM for glucocorticoid receptor, progesterone receptor, mineralocorticoid receptor, androgen receptor, estrogen receptor, respectively. AL-438 shows antiinflammatory activity .
Cat. No.: HY-P3737
CAS No.: 89458-24-2
Target:
Research Areas:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
